Aptevo Therapeutics Inc. Increase (Decrease) in Accounts Receivable
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Accounts Receivable of $1.80 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2020-11-10
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for the quarter ending 2019-12-31 was -$896.00K.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for the quarter ending 2019-09-30 was $540.00K, a 847.37% increase year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for the quarter ending 2019-06-30 was $1.58M, a 48.24% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for the quarter ending 2019-03-31 was $581.00K, a 39.29% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for fiscal 2019 was $1.80M, a 41.47% decline from fiscal 2018.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for fiscal 2018 was $3.08M, a 67.88% increase from fiscal 2017.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for fiscal 2017 was $1.83M.
- Aptevo Therapeutics Inc. increase (decrease) in accounts receivable for fiscal 2016 was -$2.17M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | -$896.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$356.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.22M derived: sum of 3 quarters · filed 2020-11-10 | $1.80M 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $540.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $2.12M derived: sum of 2 quarters · filed 2020-11-10 | $2.70M 10-Q · filed 2020-11-10 | $1.72M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.16M 10-Q · filed 2020-08-14 | $1.18M derived: sum of 3 quarters · filed 2020-08-14 | $1.23M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $581.00K 10-Q · filed 2020-05-13 | -$401.00K derived: sum of 2 quarters · filed 2020-05-13 | -$344.00K derived: sum of 3 quarters · filed 2020-05-13 | $2.70M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$925.00K derived: sum of 2 quarters · filed 2020-03-25 | $2.12M derived: sum of 3 quarters · filed 2020-03-25 | $3.08M 10-K · filed 2020-03-25 | |||
| 2018-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.10M derived: sum of 2 quarters · filed 2019-11-07 | $4.06M 10-Q · filed 2019-11-07 | $5.67M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $4.00M 10-Q · filed 2019-08-09 | $5.62M derived: sum of 3 quarters · filed 2019-08-09 | $4.61M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $957.00K 10-Q · filed 2019-05-09 | $2.57M derived: sum of 2 quarters · filed 2019-05-09 | $1.56M derived: sum of 3 quarters · filed 2019-05-09 | $2.91M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $602.00K derived: sum of 2 quarters · filed 2019-03-18 | $1.96M derived: sum of 3 quarters · filed 2019-03-18 | $1.83M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $344.00K derived: sum of 2 quarters · filed 2018-11-14 | $221.00K 10-Q · filed 2018-11-14 | $1.55M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.23M 10-Q · filed 2018-08-09 | $431.00K 10-Q · filed 2017-08-10 | $2.56M derived: sum of 3 quarters · filed 2018-08-09 | -$3.00M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | -$123.00K 10-Q · filed 2018-05-10 | -$2.36M 10-Q · filed 2017-05-12 | $1.20M derived: sum of 2 quarters · filed 2018-05-10 | -$4.35M derived: sum of 3 quarters · filed 2018-05-10 | $703.00K derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$4.23M derived: sum of 2 quarters · filed 2018-03-13 | $826.00K derived: sum of 3 quarters · filed 2018-03-13 | -$2.17M 10-K · filed 2018-03-13 | -$1.97M 10-K · filed 2017-03-31 | ||
| 2016-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$499.00K derived: sum of 2 quarters · filed 2017-11-13 | -$3.50M 10-Q · filed 2017-11-13 | -$9.37M derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | $5.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.06M 10-Q · filed 2017-08-10 | -$3.81M derived: sum of 3 quarters · filed 2017-08-10 | -$2.82M derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | -$3.00M 10-Q · filed 2017-05-12 | -$8.87M derived: sum of 2 quarters · filed 2017-05-12 | -$7.87M derived: sum of 3 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | -$5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$4.87M derived: sum of 2 quarters · filed 2017-03-31 | -$3.88M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | $996.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $1.99M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $990.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |